Is SLVTF or MRK a better dividend investment in 2026?

SLVTF currently yields 337.27% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: SLVTF offers higher current income.

What is the dividend yield difference between SLVTF and MRK?

SLVTF has a forward dividend yield of 337.27% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 334.51 percentage points.

Home › Compare › SLVTF vs MRK

SLVTF vs MRK: Dividend Comparison 2026

SLVTF yields 337.27% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 SLVTF wins by $3377.23M in total portfolio value

INVESTMENT

TIME HORIZON10 years

SLVTF

● Live price

337.27%

Share price

$0.59

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$3377.28M

Annual income

$2,133,119,970.07

Full SLVTF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — SLVTF vs MRK

📍 SLVTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	SLVTF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, SLVTF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

SLVTF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SLVTF

Annual income on $10K today (after 15% tax)

$28,667.79/yr

After 10yr DRIP, annual income (after tax)

$1,813,151,974.56/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, SLVTF beats the other by $1,813,143,646.15/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SLVTF + MRK for your $10,000?

SLVTF: 50%MRK: 50%

100% MRK50/50100% SLVTF

Portfolio after 10yr

$1688.67M

Annual income

$1,066,564,884.10/yr

Blended yield

63.16%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SLVTF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

113.1

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SLVTF buys

MRK buys

No recent congressional trades found for SLVTF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricSLVTFMRK

Forward yield	337.27% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$3377.28M ✓	$56.8K
Annual income after 10y	$2,133,119,970.07 ✓	$9,798.13
Total dividends collected	$3257.02M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare
Analyst consensus	Buy	Buy

Year-by-year: SLVTF vs MRK ($10,000, DRIP)

Year	SLVTF Portfolio	SLVTF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$44,427	$33,726.81	$11,206	$366.19	+$33.2K → SLVTF
2	$187,572	$140,035.03	$12,650	$502.35	+$174.9K → SLVTF
3	$753,256	$552,554.48	$14,407	$694.19	+$738.8K → SLVTF
4	$2,879,783	$2,073,799.16	$16,585	$967.82	+$2.86M → SLVTF
5	$10,491,057	$7,409,689.36	$19,342	$1,363.89	+$10.47M → SLVTF
6	$36,453,017	$25,227,585.18	$22,913	$1,947.19	+$36.43M → SLVTF
7	$120,927,777	$81,923,049.62	$27,662	$2,823.89	+$120.90M → SLVTF
8	$383,381,734	$253,989,012.55	$34,159	$4,173.35	+$383.35M → SLVTF
9	$1,162,770,429	$752,551,972.96	$43,337	$6,308.80	+$1162.73M → SLVTF
10	$3,377,284,329	$2,133,119,970.07	$56,776	$9,798.13	+$3377.23M → SLVTF

SLVTF vs MRK: Complete Analysis 2026

SLVTF — Stock

Silver Tiger Metals Inc. engages in the exploration and evaluation of mineral properties in Mexico. The company primarily explores for gold and silver, as well as for copper, zinc, and lead deposits. It holds a 100% interest in the El Tigre property that covers an area of 28,414 hectares located in Sonora, Mexico. The company was formerly known as Oceanus Resources Corporation and changed its name to Silver Tiger Metals Inc. in May 2020. Silver Tiger Metals Inc. was incorporated in 2010 and is headquartered in Halifax, Canada.

Full SLVTF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this SLVTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SLVTF vs SCHD SLVTF vs JEPI SLVTF vs O SLVTF vs KO SLVTF vs MAIN SLVTF vs JNJ SLVTF vs ABBV SLVTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.